Search research articles
Contact Us
Filters
Showing results (731-740 of 744) with videos related to
Page
of 75
Sort By:
Cell Reports
|
October 21, 2016
Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death
Frederick J Kohlhapp, Erica J Huelsmann, Andrew T Lacek, et al.
Cell Reports. Medicine
|
May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Chang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Journal of Medicinal Chemistry
|
March 8, 2024
Empowering Voices: Inspiring Women in Medicinal Chemistry
Maria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
Molecular Systems Biology
|
April 4, 2013
Construction of human activity-based phosphorylation networks
Robert H Newman, Jianfei Hu, Hee-Sool Rho, et al.
Cell Reports
|
March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
Aiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.
Circulation. Heart Failure
|
August 23, 2021
Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop
Jane A Leopold, Steven M Kawut, Micheala A Aldred, et al.
Nature Immunology
|
April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Matthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2019
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
Mark N Stein, Jyoti Malhotra, Rohinton S Tarapore, et al.
Cell Reports
|
December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 2020
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Jenna H Newman, C Brent Chesson, Nora L Herzog, et al.
Page
of 75
Search research articles
Search
Showing results (731-740 of 744) with videos related to
Sort By:
Page
of 75
Cell Reports
|
October 21, 2016
Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death
Frederick J Kohlhapp, Erica J Huelsmann, Andrew T Lacek, et al.
Cell Reports. Medicine
|
May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Chang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Journal of Medicinal Chemistry
|
March 8, 2024
Empowering Voices: Inspiring Women in Medicinal Chemistry
Maria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
Molecular Systems Biology
|
April 4, 2013
Construction of human activity-based phosphorylation networks
Robert H Newman, Jianfei Hu, Hee-Sool Rho, et al.
Cell Reports
|
March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
Aiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.
Circulation. Heart Failure
|
August 23, 2021
Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop
Jane A Leopold, Steven M Kawut, Micheala A Aldred, et al.
Nature Immunology
|
April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Matthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2019
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
Mark N Stein, Jyoti Malhotra, Rohinton S Tarapore, et al.
Cell Reports
|
December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 2020
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Jenna H Newman, C Brent Chesson, Nora L Herzog, et al.
Page
of 75